Global coated endotracheal tube market was valued at $126.13 million in 2020, and is projected to reach $237.99 million by 2030, growing at a CAGR of 6.5% from 2021 to 2030.
Endotracheal tube is a medical device, which is used to provide artificial airway. It is placed when a patients are unable to breathe on their own. It is inserted through the mouth or nose into the trachea (windpipe) to help a patient breathe during surgery. Coated endotracheal tube is a specific tube coated with antithrombotic agents to prevent biofilm. Coating reduces the ventilator associated pneumonia (VAP) incidence by preventing bacterial colonization and biofilm formation. The major factor that contributes to the growth of the coated endotracheal tube market includes rise in number of surgical procedures due to increase in prevalence of chronic respiratory diseases such as cardiovascular diseases, respiratory diseases, diabetes, cancer, and other lung injuries. Moreover, increase in incidence of ventilator-associated pneumonia, rise in awareness about technologically advanced endotracheal tube, and developments in the field of nanobiotechnology & drug design are the key factors projected to drive the growth of the global coated endotracheal tubes market. However, dearth of skilled professionals and post-operative risks associated with laparoscopy surgeries hamper the market growth. Conversely, developing economies provide lucrative growth opportunities for the market, due to surge in geriatric population, advanced healthcare infrastructure, and high surge in patients with VAP.
The global coated endotracheal tube market is segmented into intubation, application, end user, and region. Depending on intubation, the market is bifurcated into orotracheal intubation and nasotracheal intubation.
The applications covered in the study include anesthesia, emergency medicine, and others. On the basis of end user, the market is classified into hospital, clinics, and ambulatory surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
COVID-19 Impact
Coronavirus (COVID-19) was discovered in December 2019 in Hubei province of Wuhan city in China. The disease is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans.
After its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Moreover, this virus causes various symptoms in patients, which range from common symptoms to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement. Furthermore, the virus has high potential of lethality in geriatric population. On March 11, 2020, the World Health Organization made an assessment that COVID-19 can be characterized as pandemic. In addition, only a few vaccines that received emergency approvals for COVID-19 prevention. Thus, social distancing is observed as the most important measure to stop the spread of this disease. Furthermore, to maintain social distancing, various countries across the world have adopted nationwide lockdowns.
Almost every nation is dealing with the outbreak. Most markets are experiencing a decline, owing to the outbreak. The COVID-19 pandemic is an unprecedented global public health challenge, and is anticipated to have a positive impact on the coated endotracheal tube market. Tracheal intubation in COVID patients poses a unique set of challenges. It combines complex time-critical tasks in physiologically difficult airways. According to the American Society of Anesthesiologists, the COVID-19 outbreak has led to 80,409 diagnosed cases and 3,012 deaths in mainland China based on the data released on March 4, 2020. Approximately 3.2% of patients with COVID-19 required intubation and invasive ventilation at some point in the disease course. Moreover, providing best practices regarding intubation and ventilation for an overwhelming number of patients with COVID-19 amid an enhanced risk of cross-infection is a daunting undertaking.
Intubation segment review
Depending on intubation, the market is divided into orotracheal intubation and nasotracheal intubation. The orotracheal intubation segment accounted for the majority of market share of the global market in 2020, owing to increase in surgical procedures due to rise in prevalence of chronic respiratory diseases, surge in cases of ventilator-associated pneumonia, and increase in incidence of genetic disorders.
By Intubation
Orotracheal Intubation segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Application Segment Review
Based on coated endotracheal tube market trends by application, the market is segmented into anesthesia, emergency medicine, and others. Anesthesia segment accounted for the majority of market share of the global market in 2020 and expected to remain dominant during the forecast period, owing to rise in chronic respiratory diseases such as cardiovascular diseases, respiratory diseases, diabetes, cancer, and other lung injuries. These are the factors which is boosting the market growth.
By Application
Anesthesia segment is projected as one of the most lucrative segment.
End User Segment Review
Based on end user, the market is segmented into hospitals, clinics, and ambulatory surgical centers. The hospital segment accounted for maximum market revenue in 2020 and is anticipated to maintain its dominant position during the forecast period. This is attributed to increase in advancement of coated endotracheal tube, increase in incidence of ventilator-associated pneumonia, awareness about technologically advanced endotracheal tube, and developments in the field of nanobio application and drug design are the key factors projected to drive the global coated endotracheal tubes market.
By End User
Hospitals segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Region segment review
Based on region, the coated endotracheal tube market is analyzed across North America, Asia-Pacific, Europe and LAMEA. North America dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to the increasing case of pulmonary conditions, pneumonia, cancer, and other conditions, thus rise in demand for coated endotracheal tube in such diseases are a major factor that contributes toward the growth of the coated endotracheal tube market. However, as per coated endotracheal tube market forecast, Asia-Pacific is projected to register the highest growth rate from 2021 to 2030.
By Region
North America was holding a dominant position in 2020 and Asia-Pacific will maintain the lead over the analysis period.
This report provides comprehensive competitive analysis and profiles of prominent market players such as Bactiguard Holding AB, Avanos Medical, Hospiteknik Healthcare, Smiths Medical Plc., Fuji Systems Corp., N8 Medical LLC, Sharklet Technologies, Inc., Medtronic, Teleflex Incorporated and Venner Medical.
Key Benefits For Stakeholders
- This report provides a detailed quantitative analysis of the current trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
- An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
- The projections in this report are made by analyzing the current trends and future market potential from 2021 to 2030, in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the coated endotracheal tube market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the coated endotracheal tube market.
Coated Endotracheal Tube Market Report Highlights
| Aspects | Details |
 By Intubation |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Venner Medical GmbH, N8 Medical, LLC, Hospiteknik Healthcare, Bactiguard Holding AB, Teleflex Incorporated, C. R. Bard, Inc., Enox Biopharma Inc., Sharklet Technologies, Inc., Sonoma Pharmaceuticals Inc., Innovative Surface Technologies, Inc. |
Analyst Review
This section provides opinions of the CXOs of key companies operating in the coated endotracheal tubes industry. According to the CXOs, the adoption of endotracheal tubes is expected to increase due to rise in prevenance of various types of chronic diseases such as cardiovascular disorders and diabetes. These tubes provide proper airway management during surgical procedures and prevent the airway obstruction.
As per the CXOs, upsurge in cases of chronic diseases and increase in prevalence of diabetes make it imperative to use endotracheal tubes during intubation processes or surgeries. Moreover, increase in prevalence of ventilator associated pneumonia, advantages of coated endotracheal tubes with lesser side effects, rise in geriatric population, and surge in affordability in developing economies are projected to supplement the market growth. However, complications associated with these tubes and dearth of skilled professionals are expected to impede the market growth.
The CXOs further added that the use of coated endotracheal tubes is highest in North America, owing to increased usage of endotracheal intubation and heavy expenditure by the government on healthcare, followed by Europe and Asia-Pacific. In addition, coated endotracheal tubes providers and distributors have focused on expanding their presence in the emerging economies, which is anticipated to drive the market growth.
The total market value of Coated Endotracheal Tube Market is $126.13 million in 2020
The forecast period in the report is from 2021 to 2030
The market value of Coated Endotracheal Tube Market in 2030 was $237.99 Million
The base year for the report is 2020
Yes, Coated Endotracheal Tube companies are profiled in the report
The top companies that hold the market share in Coated Endotracheal Tube Market are Bactiguard Holding AB, Avanos Medical, Hospiteknik Healthcare, Smiths Medical PLc., Fuji Systems Corp., N8 Medical LLC, Sharklet Technologies, Inc., Medtronic, Teleflex Incorporated and Venner Medical.
No, there is no value chain analysis provided in the Coated Endotracheal Tube Market report
The key trends in the Coated Endotracheal Tube Market are to prevent or reduce the incidence of hospital acquired infection or ventilator-associated pneumonia (VAP), endotracheal tubes are coated with a drug-releasing coating that releases antimicrobial agents to inhibit bacterial growth and biofilm formation.
Loading Table Of Content...
